Spike-specific T-cell responses in COVID-19 patients successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases(2022)

引用 4|浏览11
暂无评分
摘要
The moAbs did not hinder short-term-memory spike-specific T-cell responses in the overall group of patients, however differences among moAbs must be further investigated both in vaccinated and unvaccinated individuals.
更多
查看译文
关键词
CD4,CD8,COVID-19,Immunity,Monoclonal antibodies,SARS-CoV-2,T-cell response
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要